↓ Skip to main content

Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions

Overview of attention for article published in Cannabis and Cannabinoid Research, March 2023
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#21 of 549)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
30 news outlets
blogs
2 blogs
twitter
110 X users
facebook
2 Facebook pages

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
68 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions
Published in
Cannabis and Cannabinoid Research, March 2023
DOI 10.1089/can.2021.0156
Pubmed ID
Authors

Alan D. Bell, Caroline MacCallum, Shari Margolese, Zach Walsh, Patrick Wright, Paul J. Daeninck, Enrico Mandarino, Gary Lacasse, Jagpaul Kaur Deol, Lauren de Freitas, Michelle St. Pierre, Lynne Belle-Isle, Marilou Gagnon, Sian Bevan, Tatiana Sanchez, Stephanie Arlt, Max Monahan-Ellison, James O'Hara, Michael Boivin, Cecilia Costiniuk, External Review Panel

X Demographics

X Demographics

The data shown below were collected from the profiles of 110 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 68 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 9%
Student > Postgraduate 5 7%
Student > Master 5 7%
Professor 4 6%
Student > Bachelor 4 6%
Other 16 24%
Unknown 28 41%
Readers by discipline Count As %
Medicine and Dentistry 13 19%
Biochemistry, Genetics and Molecular Biology 4 6%
Unspecified 4 6%
Nursing and Health Professions 3 4%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Other 12 18%
Unknown 29 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 320. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 May 2024.
All research outputs
#108,375
of 25,930,027 outputs
Outputs from Cannabis and Cannabinoid Research
#21
of 549 outputs
Outputs of similar age
#2,794
of 426,601 outputs
Outputs of similar age from Cannabis and Cannabinoid Research
#2
of 30 outputs
Altmetric has tracked 25,930,027 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 549 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 49.0. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 426,601 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.